Advanced in SOST-Related Sclerosing Bone Dysplasia

X Y. Chen-Xiang

No.87 Xiangya Road, 
Changsha, CN 
Advanced in SOST-Related Sclerosing Bone Dysplasia
No.87 Xiangya Road, 
Changsha, CN 
OverviewLocationsClinical Research

Overview

X Chen-Xiang practices in Changsha, China. Chen-Xiang is rated as an Advanced expert by MediFind in the treatment of SOST-Related Sclerosing Bone Dysplasia. Their top areas of expertise are Psoriasis, Melanoma, Chronic Spontaneous Urticaria (CSU), Endoscopy, and Cataract Removal.

Their clinical research consists of co-authoring 1762 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of SOST-Related Sclerosing Bone Dysplasia.

Locations

No.87 Xiangya Road, Changsha, 410008, China
Other Locations
Union Hospital, Wuhan, 430022, China
197 Rui Jin Er Road, Shanghai, 200025, China
No. 2999 Jinshan Road, Xiamen, 361000, China
No. 3 Taicheng Road, Yangling, 712100, China
No. 61, West Jiefang Road, Changsha, 410002, China
1 Minde Road, Nanchang, China
Shizi Street 188#, Suzhou, 215000, China
88 Jiefang Road, Hangzhou, 310009, China
Xiamen Branch, Xiamen, China
87 Xiangya Road, Changsha, China
No. 88 Jiefang Road, Hangzhou, China
6 Haierxiang North Road, Nantong, 226001, China
Wenzhou People's Hospital. No.57 Canghou Street, 325000, Wenzhou, China
Renmin Road 139, Changsha, 410011, China
Hankou Road 22, Nanjing, 210093, China
321 Zhongshan Road, Nanjing, 210008, China
Gansu Provincial Hospital 160 Donggang West Road, Lanzhou, 730000, China
No. 130, Changjiang West Road, Hefei, 230036, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1, Single- and Multiple-Dose Study to Assess the Safety and Pharmacokinetics of Ixekizumab (LY2439821) (Anti-IL-17 Humanized Antibody) in Chinese Patients With Psoriasis Vulgaris
A Phase 1, Single- and Multiple-Dose Study to Assess the Safety and Pharmacokinetics of Ixekizumab (LY2439821) (Anti-IL-17 Humanized Antibody) in Chinese Patients With Psoriasis Vulgaris
Enrollment Status: Completed
Publish Date: July 22, 2020
Intervention Type: Drug
Study Phase: Phase 1
Study on Approach and Standards for Diagnosis, Prevention and Control of Autism Spectrum Disorder in Children in China
Study on Approach and Standards for Diagnosis, Prevention and Control of Autism Spectrum Disorder in Children in China
Enrollment Status: Completed
Publish Date: May 16, 2017
View 1 Less Clinical Trial

1758 Total Publications

A case of Genitopatellar syndrome due to variant of KAT6B gene
A case of Genitopatellar syndrome due to variant of KAT6B gene
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: October 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chen-Xiang's expertise for a condition
ConditionClose
    View All 54 Advanced Conditions
    View All 217 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile